Erratum

Conflict of interest disclosure statements for some authors of the Heart Rhythm June supplement (5:(6S)S1-S76) were inadvertently omitted. All disclosures are submitted below.

Cellular bases for human atrial fibrillation Antony J. Workman, Kathleen A. Kane, Andrew C. Rankin	Anthony J. Workman received British Heart Foundation Basic Science Lectureship award BS/06/003. Drs. Kane and Rankin have no conflict of interest.
Visualizing ion channel dynamics at the plasma membrane James W. Smyth, Robin M. Shaw	Supported by the National Institutes of Health, National Heart, Lung, and Blood Institute, and GlaxoSmithKline Research and Education Foundation (Dr. Shaw). Dr. Smyth has no conflict of interest.
The renin-angiotensin-aldosterone system (RAAS) and cardiac arrhythmias Shahriar Iravanian, Samuel C. Dudley, Jr.	Dr. Dudley has received grants from Pfizer, owns stock in Medtronic and Johnson & Johnson, has consulted for Ortho Clinical Diagnostics and is an inventor on a patent entitled, “Oxidative Stress Markers Product Atrial Fibrillation (60/835,074).” Dr. Iravanian has no conflicts of interest.
Macroreentrant atrial tachycardia: Pathophysiological concepts Frédéric Anselme	Dr. Anselme has served on advisory boards and received lecture fees from SORIN and Medtronic.
Dynamics factors preceding the initiation of atrial fibrillation in humans Sanjiv M. Narayan, David E. Krummen	This work was supported in part by grants from the National Institutes of Health (K23 HL70529, R01 HL83359) and the Doris Duke Clinical Foundation (to Dr Narayan) and by a grant from the American College of Cardiology Foundation/Merck (to Dr Krummen). Dr. Narayan is co-inventor of a patent (U.S. patent no. 7,123,954) in the analysis of atrial tachyarrhythmias and is on the speaker's bureau for Boston Scientific and St. Jude Medical Corporations.
Pharmacotherapy for atrial arrhythmias: Present and future Michael M. Mazzini, Kevin M. Monahan	Drs. Mazzini and Monahan have no conflict of interest.
What have we learned about atrial arrhythmias from ablation of paroxysmal atrial fibri Navinder Sawhney, Gregory K. Feld	Dr. Feld is a member of the scientific advisory boards of and holds stock options in CryoCor, Inc., and Medwaves, Inc., San Diego, California. Dr. Sawhney has no conflict of interest.
What have we learned about atrial arrhythmias from ablation of chronic atrial fibrillation? Hakan Oral	Dr. Oral is a founder and equity owner of Ablation Frontiers, Inc. Dr. Oral has received research grants from St. Jude Medical and Boston Scientific.
Surgical lessons learned from the treatment of atrial fibrillation Richard J. Shemin	Dr. Shemin has no conflict of interest.
Beyond the implantable cardioverter-defibrillator: Are we making progress? James N. Weiss	Supported by NIH/NHLBI Grant P01 HL078931 and by the Laubisch and Kawata Endowments.
Electrophysiologic implications of myocardial stem cell therapies Lior Gepstein	Dr. Gepstein is one of the founders of Genegrafts, a Technion University incubator company. This study was supported in part by the Israel Science Foundation (#520/01), and by the Stephen and Nancy Grand Foundation.
Mechanistic insights into ventricular arrhythmias from mapping studies in humans Mina Attin, Raymond E. Ideker, Steven M. Pogwizd	Drs. Attin, Ideker and Pogwizd have no conflict of interest.
Catheter ablation of ventricular tachycardia: Two decades of progress David J. Wilber	Supported in part by a grant from the George M. Eisenberg Foundation. Dr. Wilber is a consultant and lecturer for Biosense/Webster, a consultant for CardioInsight, and a lecturer for St. Jude Medical (level: moderate).
“Focal” ventricular tachycardia: Insights from catheter ablation Suneet Mittal	Dr. Mittal received fellowship support from Boston Scientific and Medtronic; research support from Biotronik, Boston Scientific, Medtronic, and St. Jude Medical; and speaking honoraria from Boston Scientific, Medtronic, and St. Jude Medical. Dr. Mittal is a consultant to Bard, Biotronik, and Lifewatch.
Catheter ablation of bundle branch reentrant ventricular tachycardia Ramprakash Balasundaram, Hygriv B. Rao, Sharada Kalavakolanu, Calambur Narasimhan	Drs. Balasundaram, Rao, Kalavakolanu and Narasimhan have no conflict of interest.
Epicardial catheter ablation of ventricular tachycardia Andre d'Avila	Dr. Avila was lecturer for Biosense/Webster, Medtronic, Boston Scientific, and St. Jude Medical. Consultant for St. Jude Medical. Recipient of research grants from St. Jude Medical, Biosense, Cardiofocus, and Voyage Medical.